London-based PE firm CapVest has bought a 70% stake in German pharma company Stada, in Europe’s biggest healthcare deal of 2025 so far. Bain Capital and Cinven, the company’s joint PE owners since 2017, will continue to hold the remaining 30%.
Infrastructure investor Macquarie has bought a 40% stake in Luz Saude, Portugal’s second largest private hospital group by revenue, for a base consideration of €310 million. The deal values Luz Saude at €1.1 billion in terms of enterprise value, a 9.5x multiple of the group’s 2024 EBITDA.
OrganOx, an Oxford University spinout that has developed a new technology for preserving organs, has been bought by Japan-based med tech firm Terumo Corporation for $1.5 billion. This makes it the largest ever Oxford University spinout deal.
US PE firm Sycamore Partners has completed its $10 billion take-private of Walgreens Boots Alliance (WBA), a US healthcare, pharmacy and retail company that owns UK pharmacy chain Boots. Sycamore has decided to separate off Boots, as expected.
Two medium sized Australian radiology providers have been bought by private equity firms in separate transactions this month. Meanwhile, reports have emerged that the country’s largest imaging group, I-MED, may IPO, after a failed sale attempt.
Belgian PE firm Gimv has bought a majority stake in Novicare, a Dutch healthcare staffing company, from Dutch specialist healthcare PE investor Gilde Healthcare. Rune Aresvik, an expert on the Dutch healthcare market, tells us Novicare’s relatively unique business model has potential to be scaled within the Netherlands and possibly exported to other European countries.
Private equity firm H.I.G. Capital has acquired a majority stake in Valencia-based Avanta Salud Integral, one of Spain’s largest occupational health providers.
European mid-market PE firm Inflexion has sold European LifeCare Group (ELCG), a Denmark-based outpatient group focused on providing vaccination services with clinics in four European countries, to German PE firm Findos.
Listed Swedish digital occupational health provider MedHelp may be taken private by Finnish outpatient group Tervestaylo alongside MedHelp’s Chairman. If the offer is accepted, Terveystalo plans to gradually integrate MedHelp’s platform into Terveystalo’s own digital occupational health services in Finland.
Indian dialysis chain NephroPlus is to become a listed company. The group has filed a draft red herring prospectus with India’s capital markets regulatory body, the Securities and Exchange Board of India.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.